Q3 2018 Holdings
Filed 2018-11-14 | 57 holdings | $88.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $51.1M | 5,186,839 | 57.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $16.2M | 1,890,507 | 18.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $14.8M | 1,058,840 | 16.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.8M | 76,808 | 6.5% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $95.6K | 6,290,586 | 0.1% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $85.6K | 6,773,760 | 0.1% |
| Merus N V | COM | N5749R100 | $77.3K | 3,914,913 | 0.1% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $47.1K | 3,381,117 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $46.7K | 598,267 | 0.1% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $41.3K | 15,232,268 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $35.3K | 2,015,856 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $34.1K | 723,322 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $33.0K | 5,827,902 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $32.6K | 837,538 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $31.4K | 5,600,521 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $27.8K | 25,995,575 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $26.9K | 2,617,967 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $26.8K | 520,000 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $26.4K | 1,502,800 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $25.0K | 250,265 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $23.9K | 1,761,567 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $23.6K | 1,592,138 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $19.4K | 8,502,925 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $17.6K | 1,152,073 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $16.1K | 2,017,500 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $16.1K | 4,658,353 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $15.6K | 1,488,088 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.4K | 1,165,553 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $15.0K | 2,787,629 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $15.0K | 6,929,690 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $14.7K | 911,852 | 0.0% |
| Verastem Inc | COM | 92337C104 | $14.4K | 1,986,994 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $13.5K | 609,014 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $13.4K | 2,544,000 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $13.3K | 3,080,308 | 0.0% |
| Spring BK Pharmaceuticals Inc | COM | 849431101 | $11.5K | 953,301 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.0K | 1,233,618 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $8.6K | 4,042,989 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $8.5K | 1,930,670 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $7.5K | 3,100,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $7.2K | 218,800 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $7.2K | 3,478,326 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $7.0K | 240,000 | 0.0% |
| Merrimack Pharmaceuticals Inc(MACKEUR) | COM NEW | 590328209 | $5.9K | 1,110,588 | 0.0% |
| Tesaro Inc | COM | 881569107 | $5.5K | 140,000 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $5.5K | 625,000 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $4.1K | 5,265,000 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.1K | 643,059 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $3.9K | 360,218 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $3.4K | 1,684,636 | 0.0% |